Table 1

Summary of previous studies on utility values in populations with other eye diseases

Author (year)Study populationMean utility (time trade-off) (95% CI)Mean utility (gamble-death) (95% CI)
Brown et al (1999)8100 patients (28–87 years; 95 white and 5 black) with diabetic retinopathy and best corrected visual acuity decreased to 20/40 or worse in at least one eye0.77 (0.73 to 0.81)0.88 (0.84 to 0.92)
Brown et al (2000)985 white patients (56–85 years) with unilateral or bilateral macular degeneration in one or both eyes, with visual loss of a minimum of at least 20/40 in 1 eye0.72 (0.66 to 0.78)0.81 (0.76 to 0.86)
Brown et al (2001)10Adult patients from Wills Eye Hospital including 15 patients with complete absence of vision (NLP), 17 patients with light perception to counting fingers in the better eye (LP-CF), 33 patients with 20/200 to 20/400 in the better eye (20/200–20/400)0.26 (0.19 to 0.33) for NLP0.32 (0.20 to 0.44) for NLP
0.47 (0.33 to 0.61) for LP-CF0.60 (0.46 to 0.74) for LP-CF
0.65 (0.58 to 0.72) for 20/200–20/4000.80 (0.73 to 0.87) for 20/200–20/400